Tom Mitchell-Olds and collaborators provide a review of the evolutionary genetics of plant adaptation and emphasize the importance of field studies for understanding the evolutionary dynamics of model and non-model systems in Trends in Genetics.
Susanne Haga is a collaborator on a paper in Clinical Pharmacology and Therapeutics that suggests establishing clinical utility of pharmacogenetic testing and determining the most efficient and effective pathway to benefit for a given test is a practical and an ethical concern.
Uwe Ohler and researchers present findings that indicate significant promise for energy-based miRNA target prediction that includes a broader range of targets without having to use conservation or impose stringent seed match rules in PLoS ONE.
In Genetics in Medicine, Geoff Ginsburg and Susanne Haga assess public interest and concerns regarding sharing and storage of pharmacogenetic test results that would facilitate the reuse of pharmacogenetic data across a lifetime of care.
In The American Journal of Pathology, Joseph Nevins and collaborators seek to describe heterogeneity in terms of deregulation of signaling pathways in order to increase the knowledge of the biological features underlying individual melanomas.
In Clinical Cancer Research, Patrick Tan and collaborators from Duke-NUS explore novel molecular differences between non-small-cell lung cancers (NSCLC) from East Asian and Western European patients, identify ethnic-specific chromosomal aberrations in lung adenocarcinoma, and suggest patient ethnicity should be considered when evaluating future NSCLC therapies targeting genes located on these areas.